Trodusquemine

N/A

Report date: 2025/11/18 15:16:59
NME

Base Information

Drug NameTrodusquemine
Drug Alias NameProdulestan曲度奎明Trodulaminetrodusqueminatrodusqueminum +[7] 
ClassificationNatural product/ExtractSmall molecules > Steroids
Mechanisms of ActionProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1B
Therapy Area/IndicationsMetastatic breast cancerObesityDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDepymed IncGenaera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenaera CorporationNorthwell Health, IncDepymed Inc
Active IndicationsN/A
Inactive IndicationsMetastatic breast cancerObesityDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A